Clinical Pattern of Tolvaptan-Associated Liver Injury in Trial Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD): An Analysis of Pivotal Clinical Trials
David Alpers, James H. Lewis, Christine M. Hunt, James W. Freston, Vicente E. Torres, Hui Li, Wenchyi Wang, Molly E. Hoke, Sharin E. Roth, Lucas Westcott‐Baker, Alvin Estilo
Topics & Concepts
TolvaptanMedicineAutosomal dominant polycystic kidney diseasePlaceboInternal medicineClinical trialKidneyHeart failurePathologyAlternative medicineGenetic and Kidney Cyst DiseasesLiver Disease and TransplantationCircadian rhythm and melatonin